scinapse is loading now...
Steve Morris
University College London
120Publications
17H-index
1,052Citations
Publications 120
Newest
Published on Jan 1, 2019in Trials 2.07
Helen Blackshaw3
Estimated H-index: 3
,
Jane Vennik2
Estimated H-index: 2
+ 17 AuthorsValerie J. Lund61
Estimated H-index: 61
Published on Jan 22, 2019in Pilot and Feasibility Studies
Rebecca Meiksin3
Estimated H-index: 3
(University of London),
Elizabeth Allen33
Estimated H-index: 33
(University of London)
+ 12 AuthorsH. Luz McNaughton Reyes8
Estimated H-index: 8
(University of North Carolina at Chapel Hill)
Background Dating and relationship violence (DRV) – intimate partner violence during adolescence – encompasses physical, sexual and emotional abuse. DRV is associated with a range of adverse health outcomes including injuries, sexually transmitted infections, adolescent pregnancy and mental health issues. Experiencing DRV also predicts both victimisation and perpetration of partner violence in adulthood. Prevention targeting early adolescence is important because this is when dating behaviours b...
Source Cite
Published on Apr 1, 2019
E. Williamson , S. Denaxas + 13 AuthorsValerie J. Lund61
Estimated H-index: 61
Background: Macrolide antibiotics have demonstrated important anti-inflammatory and immunomodulatory properties in chronic rhinosinusitis (CRS) patients. However, reports of increased risks of cardiovascular events have led to safety concerns. We investigated the risk of all-cause and cardiac death, and cardiovascular outcomes, associated with macrolide use. Methodology: Observational cohort (1997-2016) using linked data from the Clinical Practice Research Datalink, Hospital Episodes Statistics,...
Source Cite
Published on Apr 1, 2019
David Osborn34
Estimated H-index: 34
(University College London),
Alexandra Burton3
Estimated H-index: 3
(University College London)
+ 24 AuthorsSarah L. Hardoon12
Estimated H-index: 12
(University College London)
Source Cite
Published on Jan 1, 2019in Health Technology Assessment 4.51
Wendy Atkin9
Estimated H-index: 9
(Imperial College London),
Amanda J. Cross47
Estimated H-index: 47
(Imperial College London)
+ 18 AuthorsPrendergast A (Imperial College London)
Source Cite
Published on Dec 1, 2018in Pilot and Feasibility Studies
Ruth Ponsford2
Estimated H-index: 2
(University of London),
Elizabeth Allen33
Estimated H-index: 33
(University of London)
+ 8 AuthorsHonor Young4
Estimated H-index: 4
(Cardiff University)
Background Since the introduction of the Teenage Pregnancy Strategy (TPS), England’s under-18 conception rate has fallen by 55%, but a continued focus on prevention is needed to maintain and accelerate progress. The teenage birth rate remains higher in the UK than comparable Western European countries. Previous trials indicate that school-based social marketing interventions are a promising approach to addressing teenage pregnancy and improving sexual health. Such interventions are yet to be tri...
1 Citations Source Cite
Published on Dec 1, 2018in BMC Cancer 3.29
Judith Offman6
Estimated H-index: 6
(King's College London),
Beth Muldrew1
Estimated H-index: 1
(Queen Mary University of London)
+ 14 AuthorsPierre Lao-Sirieix20
Estimated H-index: 20
(AstraZeneca)
Background Early detection of oesophageal cancer improves outcomes; however, the optimal strategy for identifying patients at increased risk from the pre-cancerous lesion Barrett’s oesophagus (BE) is not clear. The Cytosponge, a novel non-endoscopic sponge device, combined with the biomarker Trefoil Factor 3 (TFF3) has been tested in four clinical studies. It was found to be safe, accurate and acceptable to patients. The aim of the BEST3 trial is to evaluate if the offer of a Cytosponge-TFF3 tes...
2 Citations Source Cite
Published on Nov 1, 2018in JAMA Oncology 20.87
Nora Pashayan19
Estimated H-index: 19
(University College London),
Steve Morris17
Estimated H-index: 17
(University College London)
+ 1 AuthorsPaul Pharoah104
Estimated H-index: 104
(University of Cambridge)
Importance The age-based or “one-size-fits-all” breast screening approach does not take into account the individual variation in risk. Mammography screening reduces death from breast cancer at the cost of overdiagnosis. Identifying risk-stratified screening strategies with a more favorable ratio of overdiagnoses to breast cancer deaths prevented would improve the quality of life of women and save resources. Objective To assess the benefit-to-harm ratio and the cost-effectiveness of risk-stratifi...
15 Citations Source Cite
12345678910